Metraipolis › archive › dc_03302c56aba8
Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren's Disease — Europe PMC PMID:41009370
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41009370
- DOI
- 10.3390/ijms26188802
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T00:36:52.504Z
- SHA-256 of the archived text
06cd4452a493700fcc1596b6951a3b78127498d00510e12157abe4944fb63b5d- Stable URL of this page
https://metraipolis.com/documento/dc_03302c56aba8
How to cite
Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren's Disease — Europe PMC PMID:41009370 — Europe PMC (en), https://europepmc.org/article/MED/41009370 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03302c56aba8 (Metraipolis archive dc_03302c56aba8, sha256 06cd4452a493700fcc1596b6951a3b78127498d00510e12157abe4944fb63b5d)
BibTeX
@misc{dc03302c56aba8,
title = {Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren's Disease — Europe PMC PMID:41009370},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41009370},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03302c56aba8; sha256 06cd4452a493700fcc1596b6951a3b78127498d00510e12157abe4944fb63b5d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41009370. Agents can read the archived copy with the MCP tool read_document.